Multi-Parametric MRI Assessment of the Liver in the Dallas-FortWorth Metroplex Population

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04336618

Acronym

DFWRegistry

Enrollment

Registered

2020-04-07

Start date

2020-08-03

Completion date

2022-09-27

Last updated

2023-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Alcoholic Fatty Liver Disease

Brief summary

To build a Registry of volunteers by inviting them to get a LiverMultiScan(LMS)and collecting their contact information to seek interest in participating in future studies.

Detailed description

This is a Registry where there will be no intervention to the standard of care.Participants will be required to attend a single visit that will involve having a multi-parametric MRI at no cost to them. In addition, the invesigators will collect contact information of participants including their email address, phone number and house address so that they can be contacted to discuss possible participation in future studies which may be sponsored by Perspectum or third parties, such as pharmaceutical companies, the participants personal information shall never be shared with these third-parties. Additionally, the contact information of the participants medical providers shall be collected so that, if requested, their LMS reports can be used in their diagnostic pathway. Imaging will be performed at two Touchstone Imaging locations, one in downtown Dallas and the other in Southlake. A total of 100 participants will be enrolled over a period of 1 year.

Interventions

DEVICELiver MultiScan

The LiverMultiscan is a quick 15 minute, contrast free, non-invasive MRI scan that provides 3 liver metrics

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Male or female volunteers aged 18 years and over• * Participant willing and able to give informed consent for participation in the registry.

Exclusion criteria

* The participant may not enter the Registry if they have any contraindication to magnetic resonance imaging (standard MR

Design outcomes

Primary

Measure	Time frame
To build a Registry of volunteers by inviting them to get a LiverMultiScan(LMS)and collecting their contact information to seek their interest in participating in future studies	12 months

Secondary

Measure	Time frame
To use multi-parametric MRI (LMS) of the liver to assess the volunteer's liver health	12 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026